Cellular Dynamics Bolsters Stem-Cell Drug-Testing IP Portfolio with IUPUI License

Indiana University-Purdue University Indianapolis is the second academic institution in the last two months from which CDI has licensed IP to use pluripotent stem cells to produce large quantities of differentiated cells, particularly cardiomyocytes, as tools for drug screening.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories